Table 4 |
||||||||
|
Partial correlation coefficients of different parameters in patients with Kawasaki disease |
||||||||
|
S100A12 |
sRAGE |
Resistin × S100A12 |
Resistin/sRAGE |
S100A12/sRAGE |
WBCs |
N |
CRP |
|
|
|
||||||||
|
Resistin |
0.552*** |
-0.507*** |
0.889*** |
0.866*** |
0.696*** |
0.500*** |
0.695*** |
0.613*** |
|
S100A12 |
-0.252* |
0.777*** |
0.376** |
0.734*** |
0.339*** |
0.347*** |
0.321** |
|
|
sRAGE |
-0.374*** |
-0.575*** |
-0.547*** |
-0.533*** |
-0.614*** |
-0.566*** |
||
|
S100A12 × Resistin |
0.701*** |
0.771*** |
0.385*** |
0.530*** |
0.448*** |
|||
|
Resistin/sRAGE |
0.782*** |
0.542*** |
0.734*** |
0.668*** |
||||
|
S100A12/sRAGE |
0.529*** |
0.609*** |
0.567*** |
|||||
|
WBCs |
0.523*** |
0.449*** |
||||||
|
N |
0.639*** |
|||||||
|
|
||||||||
|
sRAGE, soluble receptor for advanced glycation end products; WBCs, white blood cells; N, neutrophils; CRP, C-reactive protein. Control variables were age and gender. *Correlation significant at the 0.05 level (2-tailed); **correlation significant at the 0.01 level (2-tailed); ***correlation significant at the 0.001 level (2-tailed). |
||||||||
|
Qi et al. Arthritis Research & Therapy 2012 14:R251 doi:10.1186/ar4094 |
||||||||